Atossa Genetics (ATOS) Misses Q2 EPS by 2c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus